Reuters
22 Sept 2025, 13:54 UTC · 51w ago
Verdict
Headline takes no side. We score ROG −0.40 across two claims — moderately bearish.
−0.40moderately bearish
More negative than 76% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
U.S. tariffs pose a threat to the Swiss pharmaceuticals sector, which is a crucial export industry.
So whatTariffs on a major, crucial export sector would directly compress margins and reduce global competitiveness for Swiss pharmaceutical companies if fully priced in by investors.
More negative than 96% of claims this week
Roche CEO Thomas Schinecker and other senior pharma executives will meet with the Swiss government on Monday to discuss the tariff threat.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 54% of claims this week
Which stocks this story touches
More negative than 76% of ticker scores this week
The CEO is meeting with the government to discuss the threat that U.S. tariffs pose to exports.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
WSJ
4h ago
+60.3%
Price is moving against the score
$131.06 vs $81.75 close before publication (Sep 19) · not market-adjusted
ROG chart →
